Biotech

All Articles

BioMarin goes Backpacking, striking RNA take care of biotech

.BioMarin is adding kindling to the R&ampD fire, attacking a fit along with CAMP4 Therapeutics for l...

Cash- strapped Gritstone starts hunt for tactical options as cancer vaccination information underwhelm

.Gritstone biography has generated financiers to look into "possible value-maximizing methods" after...

Kailera launches along with $400M series A, 4 Chinese obesity medicines

.Kailera Therapies has launched in to the increasingly crowded being overweight space with a profile...

Metsera associate with Amneal to lock down GLP-1 source

.Along with very early stage 1 records right now out in bush, metabolic ailment outfit Metsera is sq...

Rivus blog posts information to support muscle-sparing obesity medication insurance claims

.Rivus Pharmaceuticals has actually revealed the data responsible for its phase 2 obesity succeed in...

BMS pays out $110M to create T-cell treatment contract, assisting Prime acquire opportunity to advance prioritized pipeline

.Bristol Myers Squibb is paying out Top Medicine $110 million ahead of time to establish reagents fo...

Generate increases an additional $1B-plus Big Pharma collaboration

.Novartis has actually printer inked a bargain likely worth more than $1 billion with Flagship-found...

Metsera GLP-1 information cut discloses 7.5% fat loss at 36 days

.Lately debuted Metsera is unfolding some phase 1 information for its own GLP-1 receptor agonist, sh...

Flagship wishes biotechs flock to Mirai to improve hereditary medications

.Among the hereditary medications arms race, Main Pioneering is actually unveiling a brand new compa...

BioAge eyes $180M from IPO, personal placement for being overweight tests

.BioAge Labs is looking at about $180 million in preliminary earnings coming from an IPO as well as ...